Phase III trial reports survival gain for anti-B7-H3 antibody-drug conjugate in relapsed small-cell lung cancer
The TAISHAN-302 study found tambotatug pelitecan improved overall survival, progression-free survival and response…
Everything we have published, most recent first.
123 stories Page 1 of 11
The TAISHAN-302 study found tambotatug pelitecan improved overall survival, progression-free survival and response…
A phase III trial found that brain MRI surveillance without prophylactic cranial irradiation reduced the risk of…
The two firms said the venture will unite PwC India's consulting business with PwC US Advisory's India-based…
UROVO's new handset and price-checker put scanning, pricing and payment into a device a shopper carries, which changes…
HD Hyundai Heavy Industries will spend KRW 1.07 trillion on power-generation engines and SMR equipment, betting on AI…
Teater Besar, the 1,200-seat hall at Taman Ismail Marzuki, has become the first venue in Indonesia to install Spectera…
At HIMSS26 APAC in Singapore, Huawei and four partners launched AI tools for wards, pathology and clinical decisions…
Dinto Solar, spun out of a state research institute, says its heterojunction modules now reach 760 W as it works toward…
LG has opened a Singapore hub where its commercial displays are demonstrated in place, a recognition that business…
The da Vinci maker plans a 316,000-square-foot plant in Penang that will begin operating in 2028 and, the company…
Frost & Sullivan has named Blackpanda its Asia-Pacific incident response company of the year, the third consecutive…
Indonesia's state railway says more than five and a half million passengers used its facial recognition boarding gates…